PAR 15.1% 22.5¢ paradigm biopharmaceuticals limited..

Chart, page-4224

  1. 197 Posts.
    lightbulb Created with Sketch. 147
    Dungiven yes agreed the backdrop is bleak. however if (and they are big ifs ) ...

    fda approves with minimal additional costs/ oversight
    patient numbers reduce
    we get a handle on trial costs
    funding fills the gap

    ... then we are out of the woods.

    we are at peak uncertainty I feel and whilst I am nervous and getting poorer by the day, I don't think we need a huge amount of money to fill the gap and Scott / Matt I believe are doing what they've been hired to do.

    if I'm wrong I'm a fool, if I'm right then agree with you this will be a monumental turnaround in a very short space of time.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.040(15.1%)
Mkt cap ! $78.80M
Open High Low Value Volume
26.5¢ 26.5¢ 22.0¢ $503.0K 2.101M

Buyers (Bids)

No. Vol. Price($)
1 10000 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 210000 2
View Market Depth
Last trade - 16.10pm 21/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.